Children, Parents, Courts and Medical Treatment: Now Who Decides?

Area of Science:

• Medical Law
• Child Health Law
• Bioethics

Background:

• The legal capacity of minors to consent to medical treatment is a complex issue.
• Previous case law (Re R, Re W) established a court's inherent power to override a Gillick-competent child's refusal of consent.
• Recent cases address the specific challenges of puberty blockers for gender dysphoria in adolescents.

Purpose of the Study:

• To analyze three recent English High Court decisions on children's medical treatment consent.
• To examine the courts' evolving stance on the competence of minors to consent to puberty blockers.
• To explore the interplay between a minor's, parents', clinicians', and courts' decision-making powers.

Main Methods:

• Analysis of three UK High Court judgments: Re X (No 2), Bell, and AB v CD.
• Review of legal precedents regarding the competence of children and adolescents to consent to medical treatment.
• Examination of judicial reasoning concerning puberty blockers and their 'experimental' nature.

Main Results:

• Re X (No 2) affirmed the court's power to override a Gillick-competent child's refusal of treatment.
• Bell questioned the competence of minors under 16 to consent to puberty blockers due to lifelong implications.
• AB v CD allowed parents to consent to puberty blockers if the child could not or did not.

Conclusions:

• The competence of minors to consent to medical treatment, especially novel interventions like puberty blockers, remains a contentious legal area.
• The Bell decision, if upheld on appeal, could significantly alter the balance of decision-making power.
• Further judicial review is anticipated to clarify the respective roles of Gillick-competent minors, parents, clinicians, and courts in medical consent.